Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT

Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors

1998 • 4,380 citations

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

2002 • 4,254 citations

Diagnosis of gastrointestinal stromal tumors: A consensus approach

2002 • 3,361 citations

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

2002 • 1,349 citations

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

2001 • 1,267 citations

KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.

2001 • 964 citations

KIT Mutations Are Common in Incidental Gastrointestinal Stromal Tumors One Centimeter or Less in Size

2002 • 445 citations

Deleted Work

1955 • 0 citations